nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP2A6—Progesterone—uterine cancer	0.256	0.327	CbGbCtD
Methoxsalen—CYP1A1—Progesterone—uterine cancer	0.219	0.279	CbGbCtD
Methoxsalen—CYP1A2—Progesterone—uterine cancer	0.0977	0.125	CbGbCtD
Methoxsalen—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0773	0.0987	CbGbCtD
Methoxsalen—CYP3A4—Progesterone—uterine cancer	0.0512	0.0654	CbGbCtD
Methoxsalen—CYP1A2—Etoposide—uterine cancer	0.0437	0.0558	CbGbCtD
Methoxsalen—CYP3A4—Etoposide—uterine cancer	0.0229	0.0293	CbGbCtD
Methoxsalen—CYP3A4—Doxorubicin—uterine cancer	0.0156	0.02	CbGbCtD
Methoxsalen—Digestion impaired—Progesterone—uterine cancer	0.00456	0.0306	CcSEcCtD
Methoxsalen—Redness—Progesterone—uterine cancer	0.00452	0.0303	CcSEcCtD
Methoxsalen—Digestion impaired—Medroxyprogesterone Acetate—uterine cancer	0.00413	0.0277	CcSEcCtD
Methoxsalen—Tenderness—Progesterone—uterine cancer	0.0035	0.0234	CcSEcCtD
Methoxsalen—Folliculitis—Dactinomycin—uterine cancer	0.00343	0.023	CcSEcCtD
Methoxsalen—Herpes simplex—Progesterone—uterine cancer	0.00331	0.0222	CcSEcCtD
Methoxsalen—Tenderness—Medroxyprogesterone Acetate—uterine cancer	0.00317	0.0212	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Progesterone—uterine cancer	0.0028	0.0188	CcSEcCtD
Methoxsalen—CYP1A1—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.00275	0.0405	CbGpPWpGaD
Methoxsalen—Cramps of lower extremities—Medroxyprogesterone Acetate—uterine cancer	0.00254	0.017	CcSEcCtD
Methoxsalen—CYP2A13—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00246	0.0362	CbGpPWpGaD
Methoxsalen—CYP2A13—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00243	0.0358	CbGpPWpGaD
Methoxsalen—CYP2A13—Tryptophan metabolism—CYP19A1—uterine cancer	0.00224	0.033	CbGpPWpGaD
Methoxsalen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFE2L2—uterine cancer	0.00215	0.0316	CbGpPWpGaD
Methoxsalen—CYP1A1—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.00212	0.0312	CbGpPWpGaD
Methoxsalen—Infection—Carboplatin—uterine cancer	0.00206	0.0138	CcSEcCtD
Methoxsalen—Leukoderma—Epirubicin—uterine cancer	0.00206	0.0138	CcSEcCtD
Methoxsalen—CYP2A13—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.002	0.0294	CbGpPWpGaD
Methoxsalen—Leukoderma—Doxorubicin—uterine cancer	0.0019	0.0128	CcSEcCtD
Methoxsalen—CYP2A13—Metapathway biotransformation—AKR1B10—uterine cancer	0.00188	0.0277	CbGpPWpGaD
Methoxsalen—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.0123	CcSEcCtD
Methoxsalen—CYP2A13—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.00181	0.0267	CbGpPWpGaD
Methoxsalen—CYP2A13—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.00179	0.0263	CbGpPWpGaD
Methoxsalen—CYP2A13—Metapathway biotransformation—AKR1B1—uterine cancer	0.00175	0.0257	CbGpPWpGaD
Methoxsalen—Depression—Progesterone—uterine cancer	0.0017	0.0114	CcSEcCtD
Methoxsalen—Body temperature increased—Carboplatin—uterine cancer	0.00164	0.011	CcSEcCtD
Methoxsalen—Inflammation—Etoposide—uterine cancer	0.00161	0.0108	CcSEcCtD
Methoxsalen—Depression—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.0103	CcSEcCtD
Methoxsalen—Skin exfoliation—Etoposide—uterine cancer	0.00149	0.00999	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Epirubicin—uterine cancer	0.00147	0.00986	CcSEcCtD
Methoxsalen—CYP2A13—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.00147	0.0216	CbGpPWpGaD
Methoxsalen—Folliculitis—Epirubicin—uterine cancer	0.00139	0.00933	CcSEcCtD
Methoxsalen—Skin hyperpigmentation—Doxorubicin—uterine cancer	0.00136	0.00912	CcSEcCtD
Methoxsalen—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.00135	0.0199	CbGpPWpGaD
Methoxsalen—Erythema—Progesterone—uterine cancer	0.00133	0.00894	CcSEcCtD
Methoxsalen—Tension—Progesterone—uterine cancer	0.00131	0.00877	CcSEcCtD
Methoxsalen—Redness—Epirubicin—uterine cancer	0.0013	0.00869	CcSEcCtD
Methoxsalen—Nervousness—Progesterone—uterine cancer	0.0013	0.00868	CcSEcCtD
Methoxsalen—Folliculitis—Doxorubicin—uterine cancer	0.00129	0.00863	CcSEcCtD
Methoxsalen—CYP2A13—Metapathway biotransformation—AKR1C1—uterine cancer	0.00128	0.0189	CbGpPWpGaD
Methoxsalen—Muscle spasms—Progesterone—uterine cancer	0.00128	0.0086	CcSEcCtD
Methoxsalen—Ill-defined disorder—Progesterone—uterine cancer	0.00124	0.0083	CcSEcCtD
Methoxsalen—Blister—Epirubicin—uterine cancer	0.00121	0.00814	CcSEcCtD
Methoxsalen—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.0081	CcSEcCtD
Methoxsalen—Malaise—Progesterone—uterine cancer	0.0012	0.00806	CcSEcCtD
Methoxsalen—Redness—Doxorubicin—uterine cancer	0.0012	0.00804	CcSEcCtD
Methoxsalen—Vertigo—Progesterone—uterine cancer	0.0012	0.00803	CcSEcCtD
Methoxsalen—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00795	CcSEcCtD
Methoxsalen—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00793	CcSEcCtD
Methoxsalen—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00787	CcSEcCtD
Methoxsalen—CYP2A6—Fluoropyrimidine Activity—RRM2—uterine cancer	0.00116	0.0171	CbGpPWpGaD
Methoxsalen—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00116	0.00779	CcSEcCtD
Methoxsalen—CYP2A13—Metapathway biotransformation—GPX3—uterine cancer	0.00113	0.0166	CbGpPWpGaD
Methoxsalen—Blister—Doxorubicin—uterine cancer	0.00112	0.00753	CcSEcCtD
Methoxsalen—Discomfort—Progesterone—uterine cancer	0.00112	0.00752	CcSEcCtD
Methoxsalen—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00752	CcSEcCtD
Methoxsalen—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00731	CcSEcCtD
Methoxsalen—Oedema—Progesterone—uterine cancer	0.00109	0.0073	CcSEcCtD
Methoxsalen—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00728	CcSEcCtD
Methoxsalen—Infection—Progesterone—uterine cancer	0.00108	0.00725	CcSEcCtD
Methoxsalen—CYP2A13—Biological oxidations—CYP11A1—uterine cancer	0.00106	0.0156	CbGpPWpGaD
Methoxsalen—Skin disorder—Progesterone—uterine cancer	0.00106	0.00709	CcSEcCtD
Methoxsalen—CYP2A13—Metapathway biotransformation—CYP11A1—uterine cancer	0.00105	0.0154	CbGpPWpGaD
Methoxsalen—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.00104	0.0154	CbGpPWpGaD
Methoxsalen—Hypotension—Progesterone—uterine cancer	0.00102	0.00682	CcSEcCtD
Methoxsalen—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00681	CcSEcCtD
Methoxsalen—CYP2A13—Metapathway biotransformation—AKR1C3—uterine cancer	0.000987	0.0145	CbGpPWpGaD
Methoxsalen—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000986	0.00661	CcSEcCtD
Methoxsalen—Insomnia—Progesterone—uterine cancer	0.000984	0.0066	CcSEcCtD
Methoxsalen—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00098	0.00657	CcSEcCtD
Methoxsalen—CYP1A1—Oxidative Stress—NFE2L2—uterine cancer	0.000967	0.0142	CbGpPWpGaD
Methoxsalen—Dyspepsia—Progesterone—uterine cancer	0.000958	0.00642	CcSEcCtD
Methoxsalen—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000958	0.00642	CcSEcCtD
Methoxsalen—Herpes simplex—Epirubicin—uterine cancer	0.000949	0.00636	CcSEcCtD
Methoxsalen—Erythema—Dactinomycin—uterine cancer	0.000942	0.00632	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Progesterone—uterine cancer	0.000939	0.0063	CcSEcCtD
Methoxsalen—CYP1A1—Oxidative Stress—GPX3—uterine cancer	0.000923	0.0136	CbGpPWpGaD
Methoxsalen—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000921	0.00618	CcSEcCtD
Methoxsalen—Inflammation—Epirubicin—uterine cancer	0.000902	0.00605	CcSEcCtD
Methoxsalen—Feeling abnormal—Progesterone—uterine cancer	0.000897	0.00601	CcSEcCtD
Methoxsalen—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000892	0.00598	CcSEcCtD
Methoxsalen—Herpes simplex—Doxorubicin—uterine cancer	0.000878	0.00589	CcSEcCtD
Methoxsalen—Ill-defined disorder—Dactinomycin—uterine cancer	0.000874	0.00586	CcSEcCtD
Methoxsalen—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000868	0.00582	CcSEcCtD
Methoxsalen—Urticaria—Progesterone—uterine cancer	0.000864	0.0058	CcSEcCtD
Methoxsalen—Body temperature increased—Progesterone—uterine cancer	0.00086	0.00577	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000851	0.00571	CcSEcCtD
Methoxsalen—Malaise—Dactinomycin—uterine cancer	0.00085	0.0057	CcSEcCtD
Methoxsalen—Skin exfoliation—Epirubicin—uterine cancer	0.000835	0.0056	CcSEcCtD
Methoxsalen—Inflammation—Doxorubicin—uterine cancer	0.000834	0.00559	CcSEcCtD
Methoxsalen—CYP1A1—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000822	0.0121	CbGpPWpGaD
Methoxsalen—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000813	0.00545	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Epirubicin—uterine cancer	0.000803	0.00539	CcSEcCtD
Methoxsalen—Hypersensitivity—Progesterone—uterine cancer	0.000802	0.00538	CcSEcCtD
Methoxsalen—Discomfort—Dactinomycin—uterine cancer	0.000793	0.00532	CcSEcCtD
Methoxsalen—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000783	0.00525	CcSEcCtD
Methoxsalen—CYP2A13—Biological oxidations—CYP19A1—uterine cancer	0.00078	0.0115	CbGpPWpGaD
Methoxsalen—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00078	0.00523	CcSEcCtD
Methoxsalen—Skin exfoliation—Doxorubicin—uterine cancer	0.000773	0.00518	CcSEcCtD
Methoxsalen—Pruritus—Progesterone—uterine cancer	0.00077	0.00516	CcSEcCtD
Methoxsalen—CYP2A13—Metapathway biotransformation—CYP19A1—uterine cancer	0.000769	0.0113	CbGpPWpGaD
Methoxsalen—Oedema—Dactinomycin—uterine cancer	0.000769	0.00516	CcSEcCtD
Methoxsalen—Infection—Dactinomycin—uterine cancer	0.000764	0.00512	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000743	0.00499	CcSEcCtD
Methoxsalen—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000727	0.00487	CcSEcCtD
Methoxsalen—Dizziness—Progesterone—uterine cancer	0.00072	0.00483	CcSEcCtD
Methoxsalen—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000698	0.00468	CcSEcCtD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.000687	0.0101	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.000687	0.0101	CbGpPWpGaD
Methoxsalen—Rash—Progesterone—uterine cancer	0.000686	0.0046	CcSEcCtD
Methoxsalen—Dermatitis—Progesterone—uterine cancer	0.000685	0.0046	CcSEcCtD
Methoxsalen—Headache—Progesterone—uterine cancer	0.000682	0.00457	CcSEcCtD
Methoxsalen—Dysgeusia—Etoposide—uterine cancer	0.000668	0.00448	CcSEcCtD
Methoxsalen—Dermatitis bullous—Epirubicin—uterine cancer	0.000664	0.00445	CcSEcCtD
Methoxsalen—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.00066	0.00972	CbGpPWpGaD
Methoxsalen—Muscle spasms—Etoposide—uterine cancer	0.000656	0.0044	CcSEcCtD
Methoxsalen—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000652	0.00437	CcSEcCtD
Methoxsalen—CYP2A6—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000652	0.00959	CbGpPWpGaD
Methoxsalen—Nausea—Progesterone—uterine cancer	0.000646	0.00433	CcSEcCtD
Methoxsalen—Feeling abnormal—Dactinomycin—uterine cancer	0.000634	0.00425	CcSEcCtD
Methoxsalen—Ill-defined disorder—Etoposide—uterine cancer	0.000633	0.00424	CcSEcCtD
Methoxsalen—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000622	0.00417	CcSEcCtD
Methoxsalen—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000621	0.00417	CcSEcCtD
Methoxsalen—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000618	0.00414	CcSEcCtD
Methoxsalen—Malaise—Etoposide—uterine cancer	0.000615	0.00412	CcSEcCtD
Methoxsalen—Dermatitis bullous—Doxorubicin—uterine cancer	0.000615	0.00412	CcSEcCtD
Methoxsalen—Vertigo—Etoposide—uterine cancer	0.000613	0.00411	CcSEcCtD
Methoxsalen—Body temperature increased—Dactinomycin—uterine cancer	0.000608	0.00408	CcSEcCtD
Methoxsalen—CYP2A6—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.000589	0.00867	CbGpPWpGaD
Methoxsalen—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000586	0.00393	CcSEcCtD
Methoxsalen—Dry skin—Epirubicin—uterine cancer	0.000582	0.0039	CcSEcCtD
Methoxsalen—Discomfort—Etoposide—uterine cancer	0.000574	0.00385	CcSEcCtD
Methoxsalen—Hypersensitivity—Dactinomycin—uterine cancer	0.000567	0.0038	CcSEcCtD
Methoxsalen—Infection—Etoposide—uterine cancer	0.000553	0.00371	CcSEcCtD
Methoxsalen—Skin disorder—Etoposide—uterine cancer	0.000541	0.00363	CcSEcCtD
Methoxsalen—Dry skin—Doxorubicin—uterine cancer	0.000538	0.00361	CcSEcCtD
Methoxsalen—CYP1A1—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000538	0.00792	CbGpPWpGaD
Methoxsalen—CYP2A6—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000535	0.00788	CbGpPWpGaD
Methoxsalen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—uterine cancer	0.000528	0.00778	CbGpPWpGaD
Methoxsalen—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine cancer	0.000524	0.00772	CbGpPWpGaD
Methoxsalen—Hypotension—Etoposide—uterine cancer	0.00052	0.00349	CcSEcCtD
Methoxsalen—Photosensitivity reaction—Epirubicin—uterine cancer	0.000501	0.00336	CcSEcCtD
Methoxsalen—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000492	0.00724	CbGpPWpGaD
Methoxsalen—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000486	0.00715	CbGpPWpGaD
Methoxsalen—CYP1A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000486	0.00715	CbGpPWpGaD
Methoxsalen—Rash—Dactinomycin—uterine cancer	0.000485	0.00325	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Etoposide—uterine cancer	0.000481	0.00322	CcSEcCtD
Methoxsalen—CYP2A6—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000479	0.00706	CbGpPWpGaD
Methoxsalen—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000463	0.00311	CcSEcCtD
Methoxsalen—Feeling abnormal—Etoposide—uterine cancer	0.000459	0.00308	CcSEcCtD
Methoxsalen—Nausea—Dactinomycin—uterine cancer	0.000457	0.00306	CcSEcCtD
Methoxsalen—CYP1A1—Tryptophan metabolism—CYP19A1—uterine cancer	0.000448	0.00659	CbGpPWpGaD
Methoxsalen—Urticaria—Etoposide—uterine cancer	0.000442	0.00297	CcSEcCtD
Methoxsalen—Body temperature increased—Etoposide—uterine cancer	0.00044	0.00295	CcSEcCtD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.000438	0.00645	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.000438	0.00645	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—NDUFB11—uterine cancer	0.000419	0.00617	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—SRD5A2—uterine cancer	0.000419	0.00617	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Etoposide—uterine cancer	0.00041	0.00275	CcSEcCtD
Methoxsalen—CYP1A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000399	0.00587	CbGpPWpGaD
Methoxsalen—CYP2A6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000394	0.0058	CbGpPWpGaD
Methoxsalen—Pruritus—Etoposide—uterine cancer	0.000394	0.00264	CcSEcCtD
Methoxsalen—Arrhythmia—Epirubicin—uterine cancer	0.000392	0.00263	CcSEcCtD
Methoxsalen—Erythema—Epirubicin—uterine cancer	0.000382	0.00256	CcSEcCtD
Methoxsalen—CYP1A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000376	0.00553	CbGpPWpGaD
Methoxsalen—Tension—Epirubicin—uterine cancer	0.000375	0.00252	CcSEcCtD
Methoxsalen—Dysgeusia—Epirubicin—uterine cancer	0.000374	0.00251	CcSEcCtD
Methoxsalen—Nervousness—Epirubicin—uterine cancer	0.000371	0.00249	CcSEcCtD
Methoxsalen—Dizziness—Etoposide—uterine cancer	0.000368	0.00247	CcSEcCtD
Methoxsalen—Muscle spasms—Epirubicin—uterine cancer	0.000368	0.00246	CcSEcCtD
Methoxsalen—CYP2A6—NRF2 pathway—NFE2L2—uterine cancer	0.000366	0.00539	CbGpPWpGaD
Methoxsalen—Arrhythmia—Doxorubicin—uterine cancer	0.000363	0.00243	CcSEcCtD
Methoxsalen—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000362	0.00533	CbGpPWpGaD
Methoxsalen—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000357	0.00526	CbGpPWpGaD
Methoxsalen—Ill-defined disorder—Epirubicin—uterine cancer	0.000355	0.00238	CcSEcCtD
Methoxsalen—Erythema—Doxorubicin—uterine cancer	0.000354	0.00237	CcSEcCtD
Methoxsalen—Rash—Etoposide—uterine cancer	0.000351	0.00235	CcSEcCtD
Methoxsalen—Dermatitis—Etoposide—uterine cancer	0.000351	0.00235	CcSEcCtD
Methoxsalen—CYP1A1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000349	0.00514	CbGpPWpGaD
Methoxsalen—CYP2A6—NRF2 pathway—GPX3—uterine cancer	0.000349	0.00514	CbGpPWpGaD
Methoxsalen—Headache—Etoposide—uterine cancer	0.000349	0.00234	CcSEcCtD
Methoxsalen—Tension—Doxorubicin—uterine cancer	0.000347	0.00233	CcSEcCtD
Methoxsalen—Dysgeusia—Doxorubicin—uterine cancer	0.000346	0.00232	CcSEcCtD
Methoxsalen—Malaise—Epirubicin—uterine cancer	0.000345	0.00231	CcSEcCtD
Methoxsalen—Nervousness—Doxorubicin—uterine cancer	0.000344	0.0023	CcSEcCtD
Methoxsalen—Vertigo—Epirubicin—uterine cancer	0.000344	0.0023	CcSEcCtD
Methoxsalen—CYP1A2—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000343	0.00505	CbGpPWpGaD
Methoxsalen—Muscle spasms—Doxorubicin—uterine cancer	0.00034	0.00228	CcSEcCtD
Methoxsalen—Nausea—Etoposide—uterine cancer	0.000331	0.00222	CcSEcCtD
Methoxsalen—Ill-defined disorder—Doxorubicin—uterine cancer	0.000328	0.0022	CcSEcCtD
Methoxsalen—Discomfort—Epirubicin—uterine cancer	0.000322	0.00216	CcSEcCtD
Methoxsalen—Malaise—Doxorubicin—uterine cancer	0.000319	0.00214	CcSEcCtD
Methoxsalen—Vertigo—Doxorubicin—uterine cancer	0.000318	0.00213	CcSEcCtD
Methoxsalen—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000314	0.00462	CbGpPWpGaD
Methoxsalen—Oedema—Epirubicin—uterine cancer	0.000312	0.00209	CcSEcCtD
Methoxsalen—Infection—Epirubicin—uterine cancer	0.00031	0.00208	CcSEcCtD
Methoxsalen—CYP1A2—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00031	0.00456	CbGpPWpGaD
Methoxsalen—Skin disorder—Epirubicin—uterine cancer	0.000303	0.00203	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—AKR1B1—uterine cancer	0.000303	0.00446	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—STAR—uterine cancer	0.000303	0.00446	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000299	0.0044	CbGpPWpGaD
Methoxsalen—Discomfort—Doxorubicin—uterine cancer	0.000298	0.002	CcSEcCtD
Methoxsalen—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000293	0.00432	CbGpPWpGaD
Methoxsalen—Hypotension—Epirubicin—uterine cancer	0.000292	0.00196	CcSEcCtD
Methoxsalen—Oedema—Doxorubicin—uterine cancer	0.000289	0.00194	CcSEcCtD
Methoxsalen—Infection—Doxorubicin—uterine cancer	0.000287	0.00192	CcSEcCtD
Methoxsalen—CYP1A2—Tryptophan metabolism—CYP19A1—uterine cancer	0.000285	0.0042	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—CYP11A1—uterine cancer	0.000284	0.00419	CbGpPWpGaD
Methoxsalen—Insomnia—Epirubicin—uterine cancer	0.000282	0.00189	CcSEcCtD
Methoxsalen—Skin disorder—Doxorubicin—uterine cancer	0.00028	0.00188	CcSEcCtD
Methoxsalen—Dyspepsia—Epirubicin—uterine cancer	0.000275	0.00184	CcSEcCtD
Methoxsalen—Hypotension—Doxorubicin—uterine cancer	0.00027	0.00181	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000269	0.00181	CcSEcCtD
Methoxsalen—Insomnia—Doxorubicin—uterine cancer	0.000261	0.00175	CcSEcCtD
Methoxsalen—Feeling abnormal—Epirubicin—uterine cancer	0.000257	0.00172	CcSEcCtD
Methoxsalen—CYP1A1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000256	0.00377	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000254	0.00374	CbGpPWpGaD
Methoxsalen—Dyspepsia—Doxorubicin—uterine cancer	0.000254	0.0017	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000249	0.00167	CcSEcCtD
Methoxsalen—Urticaria—Epirubicin—uterine cancer	0.000248	0.00166	CcSEcCtD
Methoxsalen—Body temperature increased—Epirubicin—uterine cancer	0.000247	0.00165	CcSEcCtD
Methoxsalen—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000242	0.00356	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	0.00024	0.00353	CbGpPWpGaD
Methoxsalen—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000239	0.00352	CbGpPWpGaD
Methoxsalen—Feeling abnormal—Doxorubicin—uterine cancer	0.000238	0.0016	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—POLD1—uterine cancer	0.000238	0.0035	CbGpPWpGaD
Methoxsalen—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000231	0.0034	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Epirubicin—uterine cancer	0.00023	0.00154	CcSEcCtD
Methoxsalen—Urticaria—Doxorubicin—uterine cancer	0.000229	0.00154	CcSEcCtD
Methoxsalen—Body temperature increased—Doxorubicin—uterine cancer	0.000228	0.00153	CcSEcCtD
Methoxsalen—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000228	0.00335	CbGpPWpGaD
Methoxsalen—CYP1A1—Metapathway biotransformation—GPX3—uterine cancer	0.000225	0.00331	CbGpPWpGaD
Methoxsalen—CYP2A6—Fluoropyrimidine Activity—TP53—uterine cancer	0.000224	0.00329	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	0.000223	0.00328	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—AKR1C1—uterine cancer	0.000222	0.00327	CbGpPWpGaD
Methoxsalen—Pruritus—Epirubicin—uterine cancer	0.000221	0.00148	CcSEcCtD
Methoxsalen—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.00022	0.00324	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Doxorubicin—uterine cancer	0.000213	0.00143	CcSEcCtD
Methoxsalen—CYP1A1—Biological oxidations—CYP11A1—uterine cancer	0.000212	0.00312	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—CYP19A1—uterine cancer	0.000209	0.00308	CbGpPWpGaD
Methoxsalen—CYP1A1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000209	0.00308	CbGpPWpGaD
Methoxsalen—Dizziness—Epirubicin—uterine cancer	0.000206	0.00138	CcSEcCtD
Methoxsalen—Pruritus—Doxorubicin—uterine cancer	0.000204	0.00137	CcSEcCtD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.000203	0.00299	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000203	0.00299	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—RRM2—uterine cancer	0.000198	0.00292	CbGpPWpGaD
Methoxsalen—CYP1A1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000197	0.00291	CbGpPWpGaD
Methoxsalen—Rash—Epirubicin—uterine cancer	0.000197	0.00132	CcSEcCtD
Methoxsalen—Dermatitis—Epirubicin—uterine cancer	0.000197	0.00132	CcSEcCtD
Methoxsalen—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000196	0.00289	CbGpPWpGaD
Methoxsalen—Headache—Epirubicin—uterine cancer	0.000195	0.00131	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—DCN—uterine cancer	0.000192	0.00283	CbGpPWpGaD
Methoxsalen—Dizziness—Doxorubicin—uterine cancer	0.000191	0.00128	CcSEcCtD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000191	0.00281	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000188	0.00277	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000187	0.00275	CbGpPWpGaD
Methoxsalen—Nausea—Epirubicin—uterine cancer	0.000185	0.00124	CcSEcCtD
Methoxsalen—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000185	0.00272	CbGpPWpGaD
Methoxsalen—Rash—Doxorubicin—uterine cancer	0.000182	0.00122	CcSEcCtD
Methoxsalen—Dermatitis—Doxorubicin—uterine cancer	0.000182	0.00122	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—CYP11A1—uterine cancer	0.000181	0.00267	CbGpPWpGaD
Methoxsalen—Headache—Doxorubicin—uterine cancer	0.000181	0.00121	CcSEcCtD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.000178	0.00263	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	0.000178	0.00263	CbGpPWpGaD
Methoxsalen—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000178	0.00262	CbGpPWpGaD
Methoxsalen—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000176	0.00259	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000172	0.00253	CbGpPWpGaD
Methoxsalen—Nausea—Doxorubicin—uterine cancer	0.000171	0.00115	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—AKR1C3—uterine cancer	0.000171	0.00252	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	0.000169	0.00249	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	0.000167	0.00246	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	0.000163	0.00241	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—CYP19A1—uterine cancer	0.000156	0.0023	CbGpPWpGaD
Methoxsalen—CYP1A1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000154	0.00226	CbGpPWpGaD
Methoxsalen—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000144	0.00213	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	0.000144	0.00212	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	0.000143	0.00211	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000136	0.002	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000136	0.002	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	0.000135	0.00199	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—STK11—uterine cancer	0.000133	0.00196	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—CYP19A1—uterine cancer	0.000133	0.00196	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	0.000133	0.00196	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.00013	0.00191	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.00013	0.00191	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000126	0.00186	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	0.000126	0.00185	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	0.000122	0.0018	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.00012	0.00177	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.000114	0.00168	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	0.000114	0.00168	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—SRD5A2—uterine cancer	0.000112	0.00166	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—NDUFB11—uterine cancer	0.000112	0.00166	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	0.000111	0.00163	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	0.000108	0.00159	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	0.000106	0.00157	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	0.000104	0.00154	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	0.000103	0.00151	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—MTHFR—uterine cancer	0.0001	0.00148	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	9.98e-05	0.00147	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	9.94e-05	0.00146	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	9.8e-05	0.00144	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	9.71e-05	0.00143	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	9.16e-05	0.00135	CbGpPWpGaD
Methoxsalen—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	8.89e-05	0.00131	CbGpPWpGaD
Methoxsalen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	8.7e-05	0.00128	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.67e-05	0.00128	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.67e-05	0.00128	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—SRD5A2—uterine cancer	8.38e-05	0.00123	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—NDUFB11—uterine cancer	8.38e-05	0.00123	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.14e-05	0.0012	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—STAR—uterine cancer	8.13e-05	0.0012	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—AKR1B1—uterine cancer	8.13e-05	0.0012	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	7.79e-05	0.00115	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.68e-05	0.00113	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	7.67e-05	0.00113	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	7.57e-05	0.00111	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—POLD1—uterine cancer	6.38e-05	0.000939	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.36e-05	0.000937	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—STAR—uterine cancer	6.06e-05	0.000892	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—AKR1B1—uterine cancer	6.06e-05	0.000892	CbGpPWpGaD
Methoxsalen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	5.99e-05	0.000882	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.99e-05	0.000881	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—AKR1C1—uterine cancer	5.97e-05	0.000878	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PTEN—uterine cancer	5.58e-05	0.000821	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—NDUFB11—uterine cancer	5.34e-05	0.000786	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—SRD5A2—uterine cancer	5.34e-05	0.000786	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—EP300—uterine cancer	5.32e-05	0.000783	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—RRM2—uterine cancer	5.32e-05	0.000783	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.19e-05	0.000764	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—DCN—uterine cancer	5.16e-05	0.00076	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.9e-05	0.000721	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP11A1—uterine cancer	4.86e-05	0.000716	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—POLD1—uterine cancer	4.75e-05	0.0007	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—AKR1C3—uterine cancer	4.59e-05	0.000676	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—AKR1C1—uterine cancer	4.44e-05	0.000654	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—SRD5A2—uterine cancer	4.12e-05	0.000607	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—NDUFB11—uterine cancer	4.12e-05	0.000607	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—RRM2—uterine cancer	3.96e-05	0.000583	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—PIK3CA—uterine cancer	3.93e-05	0.000579	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—STAR—uterine cancer	3.86e-05	0.000568	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—AKR1B1—uterine cancer	3.86e-05	0.000568	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—DCN—uterine cancer	3.85e-05	0.000566	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.82e-05	0.000562	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP11A1—uterine cancer	3.62e-05	0.000533	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—STK11—uterine cancer	3.58e-05	0.000527	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP19A1—uterine cancer	3.58e-05	0.000527	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—AKR1C3—uterine cancer	3.42e-05	0.000504	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—AKT1—uterine cancer	3.21e-05	0.000473	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—POLD1—uterine cancer	3.03e-05	0.000446	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.98e-05	0.000439	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—STAR—uterine cancer	2.98e-05	0.000439	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—AKR1C1—uterine cancer	2.83e-05	0.000417	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—MTHFR—uterine cancer	2.69e-05	0.000396	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—STK11—uterine cancer	2.67e-05	0.000392	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP19A1—uterine cancer	2.67e-05	0.000392	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—RRM2—uterine cancer	2.53e-05	0.000372	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.5e-05	0.000368	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—DCN—uterine cancer	2.45e-05	0.000361	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.39e-05	0.000351	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—POLD1—uterine cancer	2.34e-05	0.000344	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP11A1—uterine cancer	2.31e-05	0.00034	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.19e-05	0.000322	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—AKR1C3—uterine cancer	2.18e-05	0.000321	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—MTHFR—uterine cancer	2e-05	0.000295	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—RRM2—uterine cancer	1.95e-05	0.000287	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—DCN—uterine cancer	1.89e-05	0.000279	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.78e-05	0.000263	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.77e-05	0.00026	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.7e-05	0.00025	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—STK11—uterine cancer	1.7e-05	0.00025	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.68e-05	0.000248	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.6e-05	0.000235	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.52e-05	0.000224	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PTEN—uterine cancer	1.5e-05	0.00022	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—EP300—uterine cancer	1.43e-05	0.00021	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.31e-05	0.000193	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—STK11—uterine cancer	1.31e-05	0.000193	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—MTHFR—uterine cancer	1.28e-05	0.000188	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.13e-05	0.000166	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PTEN—uterine cancer	1.11e-05	0.000164	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—EP300—uterine cancer	1.06e-05	0.000156	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—PIK3CA—uterine cancer	1.06e-05	0.000155	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—MTHFR—uterine cancer	9.86e-06	0.000145	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—AKT1—uterine cancer	8.62e-06	0.000127	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—PIK3CA—uterine cancer	7.86e-06	0.000116	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PTEN—uterine cancer	7.11e-06	0.000105	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—EP300—uterine cancer	6.78e-06	9.98e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—AKT1—uterine cancer	6.42e-06	9.46e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PTEN—uterine cancer	5.48e-06	8.07e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—EP300—uterine cancer	5.23e-06	7.7e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—PIK3CA—uterine cancer	5.01e-06	7.38e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—AKT1—uterine cancer	4.09e-06	6.03e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.87e-06	5.7e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—AKT1—uterine cancer	3.16e-06	4.65e-05	CbGpPWpGaD
